Quipt Home Medical Corp.

NasdaqCM:QIPT Stock Report

Market Cap: US$140.8m

Quipt Home Medical Future Growth

Future criteria checks 0/6

Quipt Home Medical is forecast to grow earnings and revenue by 36.1% and 4.2% per annum respectively while EPS is expected to grow by 31% per annum.

Key information

36.1%

Earnings growth rate

31.0%

EPS growth rate

Healthcare earnings growth17.3%
Revenue growth rate4.2%
Future return on equityn/a
Analyst coverage

Low

Last updated24 Jan 2025

Recent future growth updates

Recent updates

Quipt Home Medical receives commitment letter for $80M of credit facilities

Aug 15

Quipt Business Progresses, Stock Price Should Soon Follow

Jul 26

Quipt acquires Hometown Medical, scoops fourth firm in four months

Jul 11

Quipt: At A Turning Point, Seeking 40% Return Objective

Jun 29

Quipt Convertible Debenture Hedging Provides An Incredible Opportunity

Apr 04

Quipt's Recent Announcements Signal Good Times Ahead

Nov 30

Quipt Home Medical: Acquisitions And Earnings Breathe Life Back Into Shares

Aug 31

Quipt: Warrant Overhang Creates Attractive Prices

Jun 18

Earnings and Revenue Growth Forecasts

NasdaqCM:QIPT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2026267-3N/AN/A3
9/30/2025257-6N/A495
9/30/2024246-72535N/A
6/30/2024244-53038N/A
3/31/2024241-43843N/A
12/31/2023236-44047N/A
9/30/2023212-33037N/A
6/30/202318902634N/A
3/31/202316421929N/A
12/31/202213971726N/A
9/30/202212851726N/A
6/30/202211821726N/A
3/31/202210981523N/A
12/31/202199-101420N/A
9/30/202194-61318N/A
6/30/202187-51316N/A
3/31/202181-141415N/A
12/31/20207911314N/A
9/30/202073-41414N/A
6/30/20206701919N/A
3/31/202062-61010N/A
12/31/201963-111010N/A
9/30/201961-788N/A
6/30/201957-27102N/A
3/31/201956-181411N/A
12/31/201853-201010N/A
9/30/201855-71011N/A
6/30/201859-6N/A-4N/A
3/31/201859-7N/A-3N/A
12/31/201761-4N/A-6N/A
9/30/201761-22N/A-5N/A
6/30/201736-16N/A1N/A
3/31/201745-19N/A-8N/A
12/31/201656-29N/A-7N/A
9/30/201673-28N/A-12N/A
6/30/2016105-18N/A-9N/A
3/31/201694-25N/A-10N/A
12/31/201573-16N/A-6N/A
9/30/201554-18N/A-2N/A
6/30/201542-21N/A-4N/A
3/31/201530-7N/A3N/A
12/31/201425-4N/A0N/A
9/30/201419-1N/A-1N/A
6/30/2014120N/A0N/A
3/31/20147-1N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: QIPT is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: QIPT is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: QIPT is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: QIPT's revenue (4.2% per year) is forecast to grow slower than the US market (8.8% per year).

High Growth Revenue: QIPT's revenue (4.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if QIPT's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 04:32
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Quipt Home Medical Corp. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Doug CooperBeacon Securities Limited
William SutherlandBenchmark Company
Richard CloseCanaccord Genuity